MannKind director sells 39,051 shares under plan
MannKind Corp director Steven B. Binder reported selling 39,051 shares of common stock on 2026-08-07 in an open-market transaction under a pre-established Rule 10b5-1 trading plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MannKind Corp director Steven B. Binder reported selling 39,051 shares of common stock on 2026-08-07 in an open-market transaction under a pre-established Rule 10b5-1 trading plan. The weighted average sale price was $4.06 per share, and Binder now directly holds 785,867 shares of MannKind common stock.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock, $0.01 Par Value F2, F1 | 39,051 | $4.06 | $159K |
Footnotes (2)
- F1. Transaction occurred pursuant to Rule 10B5-1 Plan established December 2, 2025.
- F2. The weighted average sales price of the reported transaction was $4.06 based on a range of prices between $3.86 and $4.13. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Key Figures
Key Terms
Rule 10b5-1 Plan regulatory
weighted average sales price financial
open market or private transaction market
net-sell financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did MannKind (MNKD) director Steven B. Binder report?
Was the MNKD insider sale by Steven B. Binder under a Rule 10b5-1 plan?
Does the MannKind (MNKD) Form 4 show any option exercises or derivative trades?
AI-generated analysis. How Rhea-AI works. Not financial advice.